nodes	percent_of_prediction	percent_of_DWPC	metapath
Verteporfin—Ill-defined disorder—Capecitabine—breast cancer	0.000361	0.000361	CcSEcCtD
Verteporfin—Urticaria—Fluorouracil—breast cancer	0.000361	0.000361	CcSEcCtD
Verteporfin—Headache—Vinorelbine—breast cancer	0.00036	0.00036	CcSEcCtD
Verteporfin—Syncope—Docetaxel—breast cancer	0.00036	0.00036	CcSEcCtD
Verteporfin—Conjunctivitis—Methotrexate—breast cancer	0.00036	0.00036	CcSEcCtD
Verteporfin—Influenza—Doxorubicin—breast cancer	0.00036	0.00036	CcSEcCtD
Verteporfin—Anaemia—Capecitabine—breast cancer	0.00036	0.00036	CcSEcCtD
Verteporfin—Body temperature increased—Fluorouracil—breast cancer	0.000359	0.000359	CcSEcCtD
Verteporfin—Sweating—Methotrexate—breast cancer	0.000355	0.000355	CcSEcCtD
Verteporfin—Photosensitivity reaction—Epirubicin—breast cancer	0.000355	0.000355	CcSEcCtD
Verteporfin—Loss of consciousness—Docetaxel—breast cancer	0.000353	0.000353	CcSEcCtD
Verteporfin—Musculoskeletal discomfort—Paclitaxel—breast cancer	0.000352	0.000352	CcSEcCtD
Verteporfin—Malaise—Capecitabine—breast cancer	0.000351	0.000351	CcSEcCtD
Verteporfin—Cough—Docetaxel—breast cancer	0.000351	0.000351	CcSEcCtD
Verteporfin—Vertigo—Capecitabine—breast cancer	0.000349	0.000349	CcSEcCtD
Verteporfin—Hypersensitivity—Mitoxantrone—breast cancer	0.000349	0.000349	CcSEcCtD
Verteporfin—Hypersensitivity—Irinotecan—breast cancer	0.000349	0.000349	CcSEcCtD
Verteporfin—Syncope—Capecitabine—breast cancer	0.000349	0.000349	CcSEcCtD
Verteporfin—Pneumonia—Epirubicin—breast cancer	0.000349	0.000349	CcSEcCtD
Verteporfin—Hypertension—Docetaxel—breast cancer	0.000347	0.000347	CcSEcCtD
Verteporfin—Rash—Thiotepa—breast cancer	0.000346	0.000346	CcSEcCtD
Verteporfin—Dermatitis—Thiotepa—breast cancer	0.000346	0.000346	CcSEcCtD
Verteporfin—Dyspnoea—Paclitaxel—breast cancer	0.000345	0.000345	CcSEcCtD
Verteporfin—Headache—Thiotepa—breast cancer	0.000344	0.000344	CcSEcCtD
Verteporfin—Arthralgia—Docetaxel—breast cancer	0.000342	0.000342	CcSEcCtD
Verteporfin—Chest pain—Docetaxel—breast cancer	0.000342	0.000342	CcSEcCtD
Verteporfin—Loss of consciousness—Capecitabine—breast cancer	0.000342	0.000342	CcSEcCtD
Verteporfin—Nausea—Vinorelbine—breast cancer	0.000342	0.000342	CcSEcCtD
Verteporfin—Asthenia—Irinotecan—breast cancer	0.00034	0.00034	CcSEcCtD
Verteporfin—Asthenia—Mitoxantrone—breast cancer	0.00034	0.00034	CcSEcCtD
Verteporfin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—breast cancer	0.00034	0.00034	CcSEcCtD
Verteporfin—Cough—Capecitabine—breast cancer	0.000339	0.000339	CcSEcCtD
Verteporfin—Conjunctivitis—Epirubicin—breast cancer	0.000337	0.000337	CcSEcCtD
Verteporfin—Hypertension—Capecitabine—breast cancer	0.000336	0.000336	CcSEcCtD
Verteporfin—Hypersensitivity—Fluorouracil—breast cancer	0.000335	0.000335	CcSEcCtD
Verteporfin—Haemoglobin—Methotrexate—breast cancer	0.000334	0.000334	CcSEcCtD
Verteporfin—Gastrointestinal disorder—Paclitaxel—breast cancer	0.000334	0.000334	CcSEcCtD
Verteporfin—Haemorrhage—Methotrexate—breast cancer	0.000333	0.000333	CcSEcCtD
Verteporfin—Sweating—Epirubicin—breast cancer	0.000332	0.000332	CcSEcCtD
Verteporfin—Asthenia—Gemcitabine—breast cancer	0.000331	0.000331	CcSEcCtD
Verteporfin—Chest pain—Capecitabine—breast cancer	0.000331	0.000331	CcSEcCtD
Verteporfin—Arthralgia—Capecitabine—breast cancer	0.000331	0.000331	CcSEcCtD
Verteporfin—Constipation—Paclitaxel—breast cancer	0.000331	0.000331	CcSEcCtD
Verteporfin—Pain—Paclitaxel—breast cancer	0.000331	0.000331	CcSEcCtD
Verteporfin—Pharyngitis—Methotrexate—breast cancer	0.00033	0.00033	CcSEcCtD
Verteporfin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—breast cancer	0.000329	0.000329	CcSEcCtD
Verteporfin—Photosensitivity reaction—Doxorubicin—breast cancer	0.000328	0.000328	CcSEcCtD
Verteporfin—Oedema—Docetaxel—breast cancer	0.000328	0.000328	CcSEcCtD
Verteporfin—Discomfort—Capecitabine—breast cancer	0.000327	0.000327	CcSEcCtD
Verteporfin—Pruritus—Gemcitabine—breast cancer	0.000327	0.000327	CcSEcCtD
Verteporfin—Nausea—Thiotepa—breast cancer	0.000326	0.000326	CcSEcCtD
Verteporfin—Pneumonia—Doxorubicin—breast cancer	0.000323	0.000323	CcSEcCtD
Verteporfin—Shock—Docetaxel—breast cancer	0.000323	0.000323	CcSEcCtD
Verteporfin—Nervous system disorder—Docetaxel—breast cancer	0.000322	0.000322	CcSEcCtD
Verteporfin—Pruritus—Fluorouracil—breast cancer	0.000321	0.000321	CcSEcCtD
Verteporfin—Visual impairment—Methotrexate—breast cancer	0.000321	0.000321	CcSEcCtD
Verteporfin—Feeling abnormal—Paclitaxel—breast cancer	0.000319	0.000319	CcSEcCtD
Verteporfin—Skin disorder—Docetaxel—breast cancer	0.000318	0.000318	CcSEcCtD
Verteporfin—Oedema—Capecitabine—breast cancer	0.000317	0.000317	CcSEcCtD
Verteporfin—Dizziness—Irinotecan—breast cancer	0.000314	0.000314	CcSEcCtD
Verteporfin—Haemoglobin—Epirubicin—breast cancer	0.000313	0.000313	CcSEcCtD
Verteporfin—Shock—Capecitabine—breast cancer	0.000312	0.000312	CcSEcCtD
Verteporfin—Conjunctivitis—Doxorubicin—breast cancer	0.000312	0.000312	CcSEcCtD
Verteporfin—Nervous system disorder—Capecitabine—breast cancer	0.000311	0.000311	CcSEcCtD
Verteporfin—Haemorrhage—Epirubicin—breast cancer	0.000311	0.000311	CcSEcCtD
Verteporfin—Eye disorder—Methotrexate—breast cancer	0.000311	0.000311	CcSEcCtD
Verteporfin—Hypoaesthesia—Epirubicin—breast cancer	0.00031	0.00031	CcSEcCtD
Verteporfin—Pharyngitis—Epirubicin—breast cancer	0.000309	0.000309	CcSEcCtD
Verteporfin—Cardiac disorder—Methotrexate—breast cancer	0.000309	0.000309	CcSEcCtD
Verteporfin—Skin disorder—Capecitabine—breast cancer	0.000308	0.000308	CcSEcCtD
Verteporfin—Sweating—Doxorubicin—breast cancer	0.000308	0.000308	CcSEcCtD
Verteporfin—Urticaria—Paclitaxel—breast cancer	0.000307	0.000307	CcSEcCtD
Verteporfin—Hyperhidrosis—Capecitabine—breast cancer	0.000307	0.000307	CcSEcCtD
Verteporfin—Body temperature increased—Paclitaxel—breast cancer	0.000306	0.000306	CcSEcCtD
Verteporfin—Angiopathy—Methotrexate—breast cancer	0.000302	0.000302	CcSEcCtD
Verteporfin—Immune system disorder—Methotrexate—breast cancer	0.0003	0.0003	CcSEcCtD
Verteporfin—Dizziness—Fluorouracil—breast cancer	0.0003	0.0003	CcSEcCtD
Verteporfin—Visual impairment—Epirubicin—breast cancer	0.0003	0.0003	CcSEcCtD
Verteporfin—Rash—Mitoxantrone—breast cancer	0.000299	0.000299	CcSEcCtD
Verteporfin—Rash—Irinotecan—breast cancer	0.000299	0.000299	CcSEcCtD
Verteporfin—Dermatitis—Mitoxantrone—breast cancer	0.000299	0.000299	CcSEcCtD
Verteporfin—Dermatitis—Irinotecan—breast cancer	0.000299	0.000299	CcSEcCtD
Verteporfin—Musculoskeletal discomfort—Docetaxel—breast cancer	0.000299	0.000299	CcSEcCtD
Verteporfin—Headache—Mitoxantrone—breast cancer	0.000297	0.000297	CcSEcCtD
Verteporfin—Headache—Irinotecan—breast cancer	0.000297	0.000297	CcSEcCtD
Verteporfin—Dyspnoea—Docetaxel—breast cancer	0.000292	0.000292	CcSEcCtD
Verteporfin—Rash—Gemcitabine—breast cancer	0.000291	0.000291	CcSEcCtD
Verteporfin—Dermatitis—Gemcitabine—breast cancer	0.000291	0.000291	CcSEcCtD
Verteporfin—Eye disorder—Epirubicin—breast cancer	0.000291	0.000291	CcSEcCtD
Verteporfin—Malnutrition—Methotrexate—breast cancer	0.00029	0.00029	CcSEcCtD
Verteporfin—Haemoglobin—Doxorubicin—breast cancer	0.000289	0.000289	CcSEcCtD
Verteporfin—Headache—Gemcitabine—breast cancer	0.000289	0.000289	CcSEcCtD
Verteporfin—Musculoskeletal discomfort—Capecitabine—breast cancer	0.000289	0.000289	CcSEcCtD
Verteporfin—Flushing—Epirubicin—breast cancer	0.000289	0.000289	CcSEcCtD
Verteporfin—Cardiac disorder—Epirubicin—breast cancer	0.000289	0.000289	CcSEcCtD
Verteporfin—Haemorrhage—Doxorubicin—breast cancer	0.000288	0.000288	CcSEcCtD
Verteporfin—Hypoaesthesia—Doxorubicin—breast cancer	0.000287	0.000287	CcSEcCtD
Verteporfin—Rash—Fluorouracil—breast cancer	0.000286	0.000286	CcSEcCtD
Verteporfin—Dermatitis—Fluorouracil—breast cancer	0.000286	0.000286	CcSEcCtD
Verteporfin—Pharyngitis—Doxorubicin—breast cancer	0.000286	0.000286	CcSEcCtD
Verteporfin—Hypersensitivity—Paclitaxel—breast cancer	0.000285	0.000285	CcSEcCtD
Verteporfin—Headache—Fluorouracil—breast cancer	0.000285	0.000285	CcSEcCtD
Verteporfin—Gastrointestinal disorder—Docetaxel—breast cancer	0.000283	0.000283	CcSEcCtD
Verteporfin—Dyspnoea—Capecitabine—breast cancer	0.000283	0.000283	CcSEcCtD
Verteporfin—Angiopathy—Epirubicin—breast cancer	0.000282	0.000282	CcSEcCtD
Verteporfin—Nausea—Irinotecan—breast cancer	0.000282	0.000282	CcSEcCtD
Verteporfin—Nausea—Mitoxantrone—breast cancer	0.000282	0.000282	CcSEcCtD
Verteporfin—Immune system disorder—Epirubicin—breast cancer	0.000281	0.000281	CcSEcCtD
Verteporfin—Pain—Docetaxel—breast cancer	0.00028	0.00028	CcSEcCtD
Verteporfin—Constipation—Docetaxel—breast cancer	0.00028	0.00028	CcSEcCtD
Verteporfin—Back pain—Methotrexate—breast cancer	0.00028	0.00028	CcSEcCtD
Verteporfin—Visual impairment—Doxorubicin—breast cancer	0.000278	0.000278	CcSEcCtD
Verteporfin—Asthenia—Paclitaxel—breast cancer	0.000278	0.000278	CcSEcCtD
Verteporfin—Nausea—Gemcitabine—breast cancer	0.000274	0.000274	CcSEcCtD
Verteporfin—Gastrointestinal disorder—Capecitabine—breast cancer	0.000274	0.000274	CcSEcCtD
Verteporfin—Pruritus—Paclitaxel—breast cancer	0.000274	0.000274	CcSEcCtD
Verteporfin—Vision blurred—Methotrexate—breast cancer	0.000273	0.000273	CcSEcCtD
Verteporfin—Pain—Capecitabine—breast cancer	0.000271	0.000271	CcSEcCtD
Verteporfin—Constipation—Capecitabine—breast cancer	0.000271	0.000271	CcSEcCtD
Verteporfin—Malnutrition—Epirubicin—breast cancer	0.000271	0.000271	CcSEcCtD
Verteporfin—Feeling abnormal—Docetaxel—breast cancer	0.00027	0.00027	CcSEcCtD
Verteporfin—Nausea—Fluorouracil—breast cancer	0.00027	0.00027	CcSEcCtD
Verteporfin—Eye disorder—Doxorubicin—breast cancer	0.000269	0.000269	CcSEcCtD
Verteporfin—Ill-defined disorder—Methotrexate—breast cancer	0.000269	0.000269	CcSEcCtD
Verteporfin—Anaemia—Methotrexate—breast cancer	0.000268	0.000268	CcSEcCtD
Verteporfin—Flushing—Doxorubicin—breast cancer	0.000267	0.000267	CcSEcCtD
Verteporfin—Cardiac disorder—Doxorubicin—breast cancer	0.000267	0.000267	CcSEcCtD
Verteporfin—Back pain—Epirubicin—breast cancer	0.000262	0.000262	CcSEcCtD
Verteporfin—Feeling abnormal—Capecitabine—breast cancer	0.000262	0.000262	CcSEcCtD
Verteporfin—Angiopathy—Doxorubicin—breast cancer	0.000261	0.000261	CcSEcCtD
Verteporfin—Malaise—Methotrexate—breast cancer	0.000261	0.000261	CcSEcCtD
Verteporfin—Immune system disorder—Doxorubicin—breast cancer	0.00026	0.00026	CcSEcCtD
Verteporfin—Vertigo—Methotrexate—breast cancer	0.00026	0.00026	CcSEcCtD
Verteporfin—Body temperature increased—Docetaxel—breast cancer	0.000259	0.000259	CcSEcCtD
Verteporfin—Dizziness—Paclitaxel—breast cancer	0.000256	0.000256	CcSEcCtD
Verteporfin—Vision blurred—Epirubicin—breast cancer	0.000255	0.000255	CcSEcCtD
Verteporfin—Cough—Methotrexate—breast cancer	0.000253	0.000253	CcSEcCtD
Verteporfin—Urticaria—Capecitabine—breast cancer	0.000252	0.000252	CcSEcCtD
Verteporfin—Ill-defined disorder—Epirubicin—breast cancer	0.000251	0.000251	CcSEcCtD
Verteporfin—Body temperature increased—Capecitabine—breast cancer	0.000251	0.000251	CcSEcCtD
Verteporfin—Malnutrition—Doxorubicin—breast cancer	0.000251	0.000251	CcSEcCtD
Verteporfin—Anaemia—Epirubicin—breast cancer	0.00025	0.00025	CcSEcCtD
Verteporfin—Arthralgia—Methotrexate—breast cancer	0.000247	0.000247	CcSEcCtD
Verteporfin—Chest pain—Methotrexate—breast cancer	0.000247	0.000247	CcSEcCtD
Verteporfin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	0.000245	0.000245	CcSEcCtD
Verteporfin—Malaise—Epirubicin—breast cancer	0.000244	0.000244	CcSEcCtD
Verteporfin—Rash—Paclitaxel—breast cancer	0.000244	0.000244	CcSEcCtD
Verteporfin—Dermatitis—Paclitaxel—breast cancer	0.000244	0.000244	CcSEcCtD
Verteporfin—Discomfort—Methotrexate—breast cancer	0.000244	0.000244	CcSEcCtD
Verteporfin—Vertigo—Epirubicin—breast cancer	0.000243	0.000243	CcSEcCtD
Verteporfin—Syncope—Epirubicin—breast cancer	0.000243	0.000243	CcSEcCtD
Verteporfin—Back pain—Doxorubicin—breast cancer	0.000243	0.000243	CcSEcCtD
Verteporfin—Headache—Paclitaxel—breast cancer	0.000242	0.000242	CcSEcCtD
Verteporfin—Hypersensitivity—Docetaxel—breast cancer	0.000242	0.000242	CcSEcCtD
Verteporfin—Loss of consciousness—Epirubicin—breast cancer	0.000238	0.000238	CcSEcCtD
Verteporfin—Cough—Epirubicin—breast cancer	0.000236	0.000236	CcSEcCtD
Verteporfin—Vision blurred—Doxorubicin—breast cancer	0.000236	0.000236	CcSEcCtD
Verteporfin—Asthenia—Docetaxel—breast cancer	0.000235	0.000235	CcSEcCtD
Verteporfin—Hypertension—Epirubicin—breast cancer	0.000234	0.000234	CcSEcCtD
Verteporfin—Hypersensitivity—Capecitabine—breast cancer	0.000234	0.000234	CcSEcCtD
Verteporfin—Ill-defined disorder—Doxorubicin—breast cancer	0.000233	0.000233	CcSEcCtD
Verteporfin—Pruritus—Docetaxel—breast cancer	0.000232	0.000232	CcSEcCtD
Verteporfin—Nervous system disorder—Methotrexate—breast cancer	0.000232	0.000232	CcSEcCtD
Verteporfin—Anaemia—Doxorubicin—breast cancer	0.000232	0.000232	CcSEcCtD
Verteporfin—Arthralgia—Epirubicin—breast cancer	0.000231	0.000231	CcSEcCtD
Verteporfin—Chest pain—Epirubicin—breast cancer	0.000231	0.000231	CcSEcCtD
Verteporfin—Nausea—Paclitaxel—breast cancer	0.00023	0.00023	CcSEcCtD
Verteporfin—Skin disorder—Methotrexate—breast cancer	0.00023	0.00023	CcSEcCtD
Verteporfin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	0.000229	0.000229	CcSEcCtD
Verteporfin—Hyperhidrosis—Methotrexate—breast cancer	0.000228	0.000228	CcSEcCtD
Verteporfin—Discomfort—Epirubicin—breast cancer	0.000228	0.000228	CcSEcCtD
Verteporfin—Asthenia—Capecitabine—breast cancer	0.000228	0.000228	CcSEcCtD
Verteporfin—Malaise—Doxorubicin—breast cancer	0.000226	0.000226	CcSEcCtD
Verteporfin—Vertigo—Doxorubicin—breast cancer	0.000225	0.000225	CcSEcCtD
Verteporfin—Syncope—Doxorubicin—breast cancer	0.000225	0.000225	CcSEcCtD
Verteporfin—Pruritus—Capecitabine—breast cancer	0.000225	0.000225	CcSEcCtD
Verteporfin—Oedema—Epirubicin—breast cancer	0.000221	0.000221	CcSEcCtD
Verteporfin—Loss of consciousness—Doxorubicin—breast cancer	0.00022	0.00022	CcSEcCtD
Verteporfin—Cough—Doxorubicin—breast cancer	0.000219	0.000219	CcSEcCtD
Verteporfin—Shock—Epirubicin—breast cancer	0.000218	0.000218	CcSEcCtD
Verteporfin—Nervous system disorder—Epirubicin—breast cancer	0.000217	0.000217	CcSEcCtD
Verteporfin—Dizziness—Docetaxel—breast cancer	0.000217	0.000217	CcSEcCtD
Verteporfin—Hypertension—Doxorubicin—breast cancer	0.000216	0.000216	CcSEcCtD
Verteporfin—Musculoskeletal discomfort—Methotrexate—breast cancer	0.000215	0.000215	CcSEcCtD
Verteporfin—Skin disorder—Epirubicin—breast cancer	0.000215	0.000215	CcSEcCtD
Verteporfin—Hyperhidrosis—Epirubicin—breast cancer	0.000214	0.000214	CcSEcCtD
Verteporfin—Chest pain—Doxorubicin—breast cancer	0.000213	0.000213	CcSEcCtD
Verteporfin—Arthralgia—Doxorubicin—breast cancer	0.000213	0.000213	CcSEcCtD
Verteporfin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	0.000212	0.000212	CcSEcCtD
Verteporfin—Discomfort—Doxorubicin—breast cancer	0.000211	0.000211	CcSEcCtD
Verteporfin—Dyspnoea—Methotrexate—breast cancer	0.000211	0.000211	CcSEcCtD
Verteporfin—Dizziness—Capecitabine—breast cancer	0.00021	0.00021	CcSEcCtD
Verteporfin—Rash—Docetaxel—breast cancer	0.000207	0.000207	CcSEcCtD
Verteporfin—Dermatitis—Docetaxel—breast cancer	0.000207	0.000207	CcSEcCtD
Verteporfin—Headache—Docetaxel—breast cancer	0.000205	0.000205	CcSEcCtD
Verteporfin—Oedema—Doxorubicin—breast cancer	0.000205	0.000205	CcSEcCtD
Verteporfin—Gastrointestinal disorder—Methotrexate—breast cancer	0.000204	0.000204	CcSEcCtD
Verteporfin—Pain—Methotrexate—breast cancer	0.000202	0.000202	CcSEcCtD
Verteporfin—Musculoskeletal discomfort—Epirubicin—breast cancer	0.000201	0.000201	CcSEcCtD
Verteporfin—Shock—Doxorubicin—breast cancer	0.000201	0.000201	CcSEcCtD
Verteporfin—Nervous system disorder—Doxorubicin—breast cancer	0.000201	0.000201	CcSEcCtD
Verteporfin—Rash—Capecitabine—breast cancer	0.0002	0.0002	CcSEcCtD
Verteporfin—Dermatitis—Capecitabine—breast cancer	0.0002	0.0002	CcSEcCtD
Verteporfin—Headache—Capecitabine—breast cancer	0.000199	0.000199	CcSEcCtD
Verteporfin—Skin disorder—Doxorubicin—breast cancer	0.000199	0.000199	CcSEcCtD
Verteporfin—Hyperhidrosis—Doxorubicin—breast cancer	0.000198	0.000198	CcSEcCtD
Verteporfin—Dyspnoea—Epirubicin—breast cancer	0.000197	0.000197	CcSEcCtD
Verteporfin—Nausea—Docetaxel—breast cancer	0.000195	0.000195	CcSEcCtD
Verteporfin—Feeling abnormal—Methotrexate—breast cancer	0.000195	0.000195	CcSEcCtD
Verteporfin—Gastrointestinal disorder—Epirubicin—breast cancer	0.000191	0.000191	CcSEcCtD
Verteporfin—Pain—Epirubicin—breast cancer	0.000189	0.000189	CcSEcCtD
Verteporfin—Constipation—Epirubicin—breast cancer	0.000189	0.000189	CcSEcCtD
Verteporfin—Nausea—Capecitabine—breast cancer	0.000189	0.000189	CcSEcCtD
Verteporfin—Urticaria—Methotrexate—breast cancer	0.000188	0.000188	CcSEcCtD
Verteporfin—Body temperature increased—Methotrexate—breast cancer	0.000187	0.000187	CcSEcCtD
Verteporfin—Musculoskeletal discomfort—Doxorubicin—breast cancer	0.000186	0.000186	CcSEcCtD
Verteporfin—Dyspnoea—Doxorubicin—breast cancer	0.000182	0.000182	CcSEcCtD
Verteporfin—Feeling abnormal—Epirubicin—breast cancer	0.000182	0.000182	CcSEcCtD
Verteporfin—Gastrointestinal disorder—Doxorubicin—breast cancer	0.000177	0.000177	CcSEcCtD
Verteporfin—Urticaria—Epirubicin—breast cancer	0.000176	0.000176	CcSEcCtD
Verteporfin—Pain—Doxorubicin—breast cancer	0.000175	0.000175	CcSEcCtD
Verteporfin—Constipation—Doxorubicin—breast cancer	0.000175	0.000175	CcSEcCtD
Verteporfin—Body temperature increased—Epirubicin—breast cancer	0.000175	0.000175	CcSEcCtD
Verteporfin—Hypersensitivity—Methotrexate—breast cancer	0.000174	0.000174	CcSEcCtD
Verteporfin—Asthenia—Methotrexate—breast cancer	0.00017	0.00017	CcSEcCtD
Verteporfin—Feeling abnormal—Doxorubicin—breast cancer	0.000169	0.000169	CcSEcCtD
Verteporfin—Pruritus—Methotrexate—breast cancer	0.000167	0.000167	CcSEcCtD
Verteporfin—Hypersensitivity—Epirubicin—breast cancer	0.000163	0.000163	CcSEcCtD
Verteporfin—Urticaria—Doxorubicin—breast cancer	0.000163	0.000163	CcSEcCtD
Verteporfin—Body temperature increased—Doxorubicin—breast cancer	0.000162	0.000162	CcSEcCtD
Verteporfin—Asthenia—Epirubicin—breast cancer	0.000159	0.000159	CcSEcCtD
Verteporfin—Pruritus—Epirubicin—breast cancer	0.000156	0.000156	CcSEcCtD
Verteporfin—Dizziness—Methotrexate—breast cancer	0.000156	0.000156	CcSEcCtD
Verteporfin—Hypersensitivity—Doxorubicin—breast cancer	0.000151	0.000151	CcSEcCtD
Verteporfin—Rash—Methotrexate—breast cancer	0.000149	0.000149	CcSEcCtD
Verteporfin—Dermatitis—Methotrexate—breast cancer	0.000149	0.000149	CcSEcCtD
Verteporfin—Headache—Methotrexate—breast cancer	0.000148	0.000148	CcSEcCtD
Verteporfin—Asthenia—Doxorubicin—breast cancer	0.000147	0.000147	CcSEcCtD
Verteporfin—Dizziness—Epirubicin—breast cancer	0.000146	0.000146	CcSEcCtD
Verteporfin—Pruritus—Doxorubicin—breast cancer	0.000145	0.000145	CcSEcCtD
Verteporfin—Nausea—Methotrexate—breast cancer	0.00014	0.00014	CcSEcCtD
Verteporfin—Rash—Epirubicin—breast cancer	0.000139	0.000139	CcSEcCtD
Verteporfin—Dermatitis—Epirubicin—breast cancer	0.000139	0.000139	CcSEcCtD
Verteporfin—Headache—Epirubicin—breast cancer	0.000139	0.000139	CcSEcCtD
Verteporfin—Dizziness—Doxorubicin—breast cancer	0.000135	0.000135	CcSEcCtD
Verteporfin—Nausea—Epirubicin—breast cancer	0.000131	0.000131	CcSEcCtD
Verteporfin—Rash—Doxorubicin—breast cancer	0.000129	0.000129	CcSEcCtD
Verteporfin—Dermatitis—Doxorubicin—breast cancer	0.000129	0.000129	CcSEcCtD
Verteporfin—Headache—Doxorubicin—breast cancer	0.000128	0.000128	CcSEcCtD
Verteporfin—Nausea—Doxorubicin—breast cancer	0.000122	0.000122	CcSEcCtD
